Entering text into the input field will update the search result below

Depomed and Horizon Pharma end legal spat

Apr. 25, 2016 12:07 PM ETAssertio Holdings, Inc. (ASRT) StockASRT, HZNPBy: Douglas W. House, SA News Editor
  • In a regulatory filing, Depomed (DEPO -0.3%) reports that, by mutual agreement, it has ended its legal fight with Horizon Pharma (HZNP -3%) stemming from the latter's unsolicited hostile offer and its alleged misuse of confidential information related to NUCYNTA (tapentadol). Both firms agreed to settle their respective claims against each other.
  • Horizon also agreed to maintain the confidentiality of applicable information related to NUCYNTA that it received from Janssen Pharmaceuticals and not use said information. It also committed to not initiate another hostile bid for Depomed through January 1, 2020.

Recommended For You

More Trending News

About ASRT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ASRT--
Assertio Holdings, Inc.